✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Testides
Batch BPC-CA-25L-01
Verification Progress
Recovery Compound
BPC-157 is a synthetic peptide studied in laboratory and preclinical research for its potential effects on tissue repair mechanisms, including cellular signaling related to inflammation and wound healing. Researchers investigate how it may influence molecular processes related to cell communication, vascular signaling, and protein regulation.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
BPC-157 is a synthetic peptide derived from a fragment of a naturally occurring gastric protein. It is produced for laboratory research and studied within controlled experimental environments.
In scientific literature, BPC-157 has been explored for its involvement in angiogenic and inflammatory signaling processes, contributing to ongoing research focused on cellular response mechanisms and structural recovery models.
Third-party tested for purity, ID, quantity.
BPC-157 (Body Protection Compound-157) is a stable 15–amino acid peptide fragment first characterized in the early 1990s during investigations of gastric cytoprotective compounds. Since its identification, it has been evaluated across multiple preclinical research models.
Experimental studies have examined its influence on angiogenesis, nitric oxide pathways, collagen organization, and cytoprotective signaling. Within controlled laboratory settings, these findings have positioned BPC-157 as a compound of continued interest in structural integrity, connective tissue research, and systemic resilience models.
BPC-157 was originally synthesized during research into protective peptides present in gastric tissue. Early experimental models focused on gastrointestinal integrity, with subsequent investigations expanding into musculoskeletal, vascular, and dermal systems.
Over time, BPC-157 became a recurring subject in laboratory research due to its measurable biological activity across diverse preclinical models.
Preclinical investigations have explored BPC-157 in structural, vascular, and inflammatory research models. Laboratory data suggest involvement in angiogenic signaling, nitric oxide modulation, collagen-related pathways, and cytoprotective mechanisms under experimental conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains the labeled quantity (12mg or 20mg) of lyophilized BPC-157. Independent third-party analysis verifies purity, identity, and net content per batch.
The vial contains only the lyophilized compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313–327.
PubMedGastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res 21(6):976–983.
PubMedThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985) 110(3):774–780.
PubMedBody protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther 9:2485–2499.
PubMedModulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep 10(1):17078.
PubMedStable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World J Gastroenterol 23(48):8465–8488.
PubMedThe effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats. Brain Behav 10(8):e01726.
PubMedPentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion. World J Hepatol 12(5):184–206.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
